| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
LRRK1 Blocking Peptide for STJ501636 is synthetically produced from the 1950-2015 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
LRRK1 |
| Gene ID: |
79705 |
| Uniprot ID: |
LRRK1_HUMAN |
| Immunogen Region: |
1950-2015 |
| Specificity: |
This blocking peptide is recommended for use in combination with LRRK1 antibody, STJ501636 |
| Immunogen: |
Synthetic peptide taken within amino acid region 1950-2015 on human Leucine-rich repeat serine/threonine-protein kinase 1 protein. |
| Function | Plays a role in the negative regulation of bone mass, acting through the maturation of osteoclasts. |
| Peptide Name | Leucine-Rich Repeat Serine/Threonine-Protein Kinase 1 |
| Cellular Localisation | Cytoplasm |
| Alternative Peptide Names | Leucine-Rich Repeat Serine/Threonine-Protein Kinase 1 proteinLRRK1 proteinKIAA1790 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
